Product Information
MUPIROCIN 2% CREAM is a generic product labeled by Encube Ethicals, Inc., priced at $0.8830 per GM under NDC 21922002905. Its NADAC has been published 262 times since Sep 29, 2021.
FDA first approved this application on Aug 31, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 g/100g
Manufacturer
Encube Ethicals, Inc.NDC
21922002905
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
MUPIROCIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA213076FDA Approved
8/31/2021
TE Code
AB
On Market Since
9/2/2021
Pharmacological Classes
Price Statistics
The NADAC for MUPIROCIN 2% CREAM has been published 262 times since Sep 29, 2021, and over the history we have for it it has declined 88.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8830 per GM |
|---|---|
| All-time high | $8.0413 (Dec 15, 2021) |
| All-time low | $0.6906 (Aug 21, 2024) |
| 52-week high | $0.9526 |
| 52-week low | $0.7642 |
| Median price | $1.1472 |
| Average price | $2.1362 |
| Largest weekly change | +59.1% (Mar 22, 2023) |
| Weeks tracked | 262 |
| Tracking since | Sep 29, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mupirocin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
RNA Synthetase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUPIROCIN 2% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for MUPIROCIN 2% CREAM, manufactured by Encube Ethicals, Inc., is $0.8830 per GM (NDC 21922002905), effective Sep 30, 2026.
How has the price of MUPIROCIN 2% CREAM changed over time?
Over the history we have for it, the NADAC for MUPIROCIN 2% CREAM has declined 88.0%. It has been tracked across 262 weekly CMS publications since Sep 29, 2021.
What are the highest and lowest recorded NADAC prices for MUPIROCIN 2% CREAM?
Since Sep 29, 2021, the NADAC for MUPIROCIN 2% CREAM has ranged from a low of $0.6906 (Aug 21, 2024) to a high of $8.0413 (Dec 15, 2021), with a median of $1.1472 per GM.
Are there cheaper alternatives to MUPIROCIN 2% CREAM?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MUPIROCIN 2% CREAM, is $0.8260 per GM — about 6% below MUPIROCIN 2% CREAM.
Who manufactures MUPIROCIN 2% CREAM?
MUPIROCIN 2% CREAM (NDC 21922002905) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.